Effects of L-propionylcarnitine on Electrical and Mechanical Alterations Induced by Amphiphilic Lipids in Isolated Guinea Pig Ventricular Muscle
Overview
Affiliations
We examined the effects of L-propionylcarnitine (Prop. C), a short-chain acylcarnitine, on amphiphile (L-lysophosphatidylcholine or L-palmitoylcarnitine)-induced electrophysiological and ultrastructural changes in isolated guinea pig ventricular papillary muscles, under acidic conditions (pH 6.9). Conventional microelectrode, tension-recording, and electron microscope techniques were used. Both amphiphiles, at a concentration of 10(-4) M, significantly decreased the resting membrane potential, action potential amplitude, and action potential duration, but increased the developed and resting tension. Such amphiphile-induced electrical changes were not observed in muscles pretreated with the beta-blocker, atenolol, although the mechanical changes remained unaffected. The application of Prop. C (10(-2) M), in the continued presence of the amphiphiles caused a return of the action potential duration and the developed tension to the control level. However, the resting potential and action potential amplitude remained unaffected; in fact, the maximum upstroke velocity (Vmax) of the action potential tended to decrease further. Pretreatment with Prop. C prevented all the amphiphile-induced electrophysiological and mechanical changes, except for Vmax. Electron microscopic studies revealed that amphiphile-induced ultrastructural changes were prevented, at least in part, in the presence of Prop. C. Thus, Prop. C antagonizes some of deleterious effects of amphiphiles, such as lysophosphatidylcholine and palmitoylcarnitine, upon the electrical and mechanical activities of the ventricular muscle, under acidic conditions.
Long-Chain Acylcarnitines and Cardiac Excitation-Contraction Coupling: Links to Arrhythmias.
Aitken-Buck H, Krause J, Zeller T, Jones P, Lamberts R Front Physiol. 2020; 11:577856.
PMID: 33041874 PMC: 7518131. DOI: 10.3389/fphys.2020.577856.
Sato T, Imanishi S, Arita M, Shimada T Heart Vessels. 1993; 8(2):71-8.
PMID: 8314740 DOI: 10.1007/BF01744386.
Sato T, Arita M, Kiyosue T Cardiovasc Drugs Ther. 1993; 7 Suppl 3:575-84.
PMID: 8251427 DOI: 10.1007/BF00877623.
Barbieri M, Carbonin P, Cerbai E, Gambassi Jr G, LO GIUDICE P, Masini I Br J Pharmacol. 1991; 102(1):73-8.
PMID: 2043933 PMC: 1917891. DOI: 10.1111/j.1476-5381.1991.tb12134.x.
Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.
Paulson D, Shug A, Zhao J Mol Cell Biochem. 1992; 116(1-2):131-7.
PMID: 1480141 DOI: 10.1007/BF01270580.